Kill Two Birds with One Stone: A Multifunctional Dual‐Targeting Protein Drug to Overcome Imatinib Resistance in Philadelphia Chromosome‐Positive Leukemia

Abstract The Bcr/Abl plays a central role in Philadelphia chromosome‐positive (Ph+) leukemia because of the constitutively activated Abl tyrosine kinase and its downstream pathways. Currently, the clinical treatment of imatinib‐resistant patients with tyrosine kinase inhibitors is severely limited b...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bohan Ma, Hui Feng, Chao Feng, Yi Liu, Hailing Zhang, Jincheng Wang, Wenjuan Wang, Pengcheng He, Fan Niu
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley 2022-05-01
Colecção:Advanced Science
Assuntos:
Bcr/Abl T315I
Bcr/Abl tetramerization domain
drug resistance
PROTAC
protein drug
Acesso em linha:https://doi.org/10.1002/advs.202104850
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados